ENvue Medical (FEED) insider’s stake falls below 10% after merger dilution

Rhea-AI Filing Summary

ENvue Medical, Inc. insider Christian Michael Glibert filed a Form 4 showing no change in his share count, while his beneficial ownership percentage dropped below 10 percent. He continues to hold 240,000 shares of Common Stock directly. The footnote explains that his reduced percentage resulted from dilution after ENvue issued additional shares in connection with a merger described in its Form 10-K, meaning no shares were acquired or disposed of by him.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Glibert Christian Michael

Role Insider

Type	Security	Shares	Price	Value
Other	Common Stock	0	$0.00	--

Holdings After Transaction: Common Stock — 240,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares owned after event: 240,000 shares Ownership threshold status: Below 10 percent Transaction code: J +1 more

4 metrics

Shares owned after event 240,000 shares Common Stock directly owned following reported change

Ownership threshold status Below 10 percent Beneficial ownership percentage after dilution

Transaction code J Other acquisition or disposition; no shares traded

Reported share change 0 shares No shares acquired or disposed of in this event

Key Terms

beneficial ownership, dilution, merger, Form 10-K, +1 more

5 terms

beneficial ownership financial

"The Reporting Person's percentage of beneficial ownership dropped below 10 percent due to dilution"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

dilution financial

"dropped below 10 percent due to dilution resulting from the Issuer's issuance of shares"

Dilution occurs when a company issues additional shares, increasing the total number of shares outstanding. This can reduce the ownership percentage and voting power of existing shareholders, similar to slicing a pie into more pieces—each piece becomes smaller. For investors, dilution can mean a reduced stake in the company and potentially lower earnings per share, affecting the value of their investment.

merger financial

"dilution resulting from the Issuer's issuance of shares in connection with a merger"

A merger is when two companies combine into a single business, with ownership and control reorganized so they operate as one entity. For investors it matters because mergers can change the value and risk of holdings—shares may be exchanged, diluted, or rise if the combined company saves costs or gains market power, and the deal often depends on regulatory approval and successful integration like two households joining resources and routines.

Form 10-K regulatory

"as reported in the Issuer's Form 10-K filed on April 15, 2026"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

Other acquisition or disposition regulatory

"transaction_code_description: "Other acquisition or disposition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glibert Christian Michael

(Last) (First) (Middle)

4001 GREEN HERON SPRING DRIVE

(Street)

CARPINTERIA CALIFORNIA 93013

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ENvue Medical, Inc. [ FEED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			No longer a 10% holder

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		J(1)		0	A	$0	240,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person's percentage of beneficial ownership dropped below 10 percent due to dilution resulting from the Issuer's issuance of shares in connection with a merger, as reported in the Issuer's Form 10-K filed on April 15, 2026. No shares were disposed of or acquired by the Reporting Person.

	/s/ Christian Michael Glibert	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

Why did Christian Michael Glibert file a Form 4 for ENvue Medical (FEED)?

He filed the Form 4 to report that his percentage of beneficial ownership in ENvue Medical dropped below 10 percent. This change was due to dilution from ENvue issuing shares in connection with a merger, not because he bought or sold any shares.

Did Christian Michael Glibert buy or sell ENvue Medical (FEED) shares in this Form 4?

No, the Form 4 explicitly states no shares were acquired or disposed of by Christian Michael Glibert. His ownership percentage changed only because ENvue issued additional shares in a merger, which diluted his stake without any trading activity on his part.

How many ENvue Medical (FEED) shares does Christian Michael Glibert own after this filing?

After the reported event, he directly owns 240,000 shares of Common Stock of ENvue Medical. The filing clarifies that this share count did not change; only his percentage ownership declined because the company issued more shares in a merger transaction.

What caused Christian Michael Glibert’s beneficial ownership in ENvue Medical (FEED) to fall below 10 percent?

His beneficial ownership dropped below 10 percent due to dilution from ENvue issuing shares in connection with a merger. According to the footnote, this issuance, reported in ENvue’s Form 10-K, reduced his percentage even though he neither bought nor sold any shares.

What does transaction code "J" mean in this ENvue Medical (FEED) Form 4?

Transaction code "J" indicates an "Other acquisition or disposition" type of event. In this case, the Form 4 and footnote clarify that it reflects a change in percentage ownership from dilution after a merger-related share issuance, with no actual share purchases or sales.

Is Christian Michael Glibert still a 10% holder of ENvue Medical (FEED) after this Form 4?

No, the Form 4 notes he is "no longer a 10% holder" of ENvue Medical. His percentage dropped below the 10 percent threshold solely because the company issued additional shares in a merger, not because he changed his personal share holdings.